bone marrow-derived cardiopoietic cells
Cell therapyexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
2
Phase 4
0
Earliest trial started Dec 1, 2008 (NCT00810238)
Timeline
Indications
Studied for
Mechanism of action
- Cardiac muscle cellTissue restoration
Cardiac muscle cell tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- bone marrow-derived cardiopoietic cells
- c3bs-cqr-1
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01768702 | Phase 3 | Nov 1, 2012 | Celyad, Mayo Clinic, OLV Ziekenhuis Aalst |
| NCT00810238 | Phase 2/Phase 3 (Phase 3) | Dec 1, 2008 | Celyad, Mayo Clinic, VZW Cardiovascular Research Center Aalst |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Celyad | For profit | 2 | 2 | 1 | 2008 |
| Mayo Clinic | Academic/Hospital | 2 | 0 | 1 | 2008 |
| OLV Ziekenhuis Aalst | Academic/Hospital | 1 | 0 | 1 | 2012 |
| VZW Cardiovascular Research Center Aalst | Academic/Hospital | 1 | 0 | 1 | 2008 |
4 organizations
Page 1 / 1